MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impairment of SHH signaling in PD LRRK2 I1371V iPSC derived floor plate cells contribute to ontogenic origin of lower dopaminergic-neuron yield

I. Datta, S. Jagtap, C. Potdar, K. Singh (Bengaluru, India)

Meeting: 2023 International Congress

Abstract Number: 1462

Keywords: Dopaminergic neurons, Leucine-rich repeat kinase 2(LRRK2), Stem cells. See also Human embryonic stem cells

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: To estimate SHH responsiveness & signaling of Floor Plate Cells (FPCs) derived from LRRK2 I1371V PD patient-iPSCs along with its link with LRRK2 I1371V mutation through membrane fluidity & Rab8A phosphorylation.

Background: A loss of 50-60% of midbrain dopaminergic neurons (mDAn) manifests in motor symptoms in PD, suggesting that a lower number of mDAn increases susceptibility of individuals to PD. To date, many LRRK2 mutant variants have been identified, & it shows differences in geographical distributions, disease risk, age of onset, brain pathology, drug response etc. Experimental embryology studies indicate that mDAn depend on SHH morphogen from ventral neural tube & floor plate.

Method: FPCs were characterized for SHH receptors Patched1 (Ptch1), Smoothened (Smo) & Glioma-Associated Oncogene Homolog 1 (Gli1) by FACS & immunofluorescence. Functional characterization of the FPCs was performed to assess intracellular Ca2+ response by live cell imaging & estimation of cellular cyclic-AMP (cAMP) by ELISA. Neurite & axon degeneration was noted using fluorescence microscopy.

Results: LRRK2 I1371V PD iPSCs gave rise to reduced yield of mDANs.  Total expression of SHH receptors Ptch1 & Smo was comparable between HC & LRRK2 I1371V FPCs however, distinct reduced cell-surface expression of Ptch1 & Smo. A corresponding decreased nuclear translocation of transcription factor Gli1 was observed. PD FPCs had compromised intracellular Ca2+ response on exposure to SHH along with elevated levels of cAMP. LRRK2 I1371V FPCs showed high substrate phosphorylation of Rab8A. A concurrent increase in membrane fluidity was observed in LRRK2 I1371V FPCs along with reduced cell-surface expression of Caveolin1(lipid raft marker). Reduced neurite extension & axon degeneration was detected.

Conclusion: The impaired SHH responsiveness of LRRK2 I1371V PD FPCs imparts to the lesser yield of mDAn during ontology.  The reduced cell surface expression of the SHH receptors is influenced by the alteration in the membrane fluidity rendered by increased substrate phosphorylation of Rab8a by LRRK2. The mutation alters membrane fluidity & membrane related morphology such as neurite length & axon degeneration.

fig 1

fig 2

fig 3

To cite this abstract in AMA style:

I. Datta, S. Jagtap, C. Potdar, K. Singh. Impairment of SHH signaling in PD LRRK2 I1371V iPSC derived floor plate cells contribute to ontogenic origin of lower dopaminergic-neuron yield [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/impairment-of-shh-signaling-in-pd-lrrk2-i1371v-ipsc-derived-floor-plate-cells-contribute-to-ontogenic-origin-of-lower-dopaminergic-neuron-yield/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impairment-of-shh-signaling-in-pd-lrrk2-i1371v-ipsc-derived-floor-plate-cells-contribute-to-ontogenic-origin-of-lower-dopaminergic-neuron-yield/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley